Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II

Breast Cancer Research

Volumn 10, Issue 4, 2008, Pages

  Feigelson, Heather S ^a   Teras, Lauren R ^a   Diver, W Ryan ^a   Tang, Weining ^b   Patel, Alpa V ^a   Stevens, Victoria L ^a   Calle, Eugenia E ^a   Thun, Michael J ^a   Bouzyk, Mark ^b  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GHRELIN; GHRL PROTEIN, HUMAN; HSD11B1 PROTEIN, HUMAN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; IRS2 PROTEIN, HUMAN;

ADIPOSE TISSUE; ARTICLE; BREAST TUMOR; COHORT ANALYSIS; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; METABOLISM; OBESITY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; BREAST NEOPLASMS; COHORT STUDIES; GENETIC VARIATION; GENOTYPE; GHRELIN; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RISK;

EID: 57149123434     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2114     Document Type: Article

References (32)

1. World Cancer Research Fund Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective 2007, Washington, DC: AICR, World Cancer Research Fund.
2. Calle E, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer 2004, 4:579-591. 15286738, 10.1038/nrc1408.
3. Feigelson HS, Patel AV, Teras LR, Gansler T, Thun MJ, Calle EE. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer 2006, 107:12-21. 16718671, 10.1002/cncr.21965.
4. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995, 87:1297-1302. 7658481, 10.1093/jnci/87.17.1297.
5. Potischman N, Swanson C, Siiteri P, Hoover R. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996, 88:756-758. 8637031, 10.1093/jnci/88.11.756.
6. Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K. Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res 2001, 3:264-269. 11434877, 10.1186/bcr304, 34110.
7. McKean-Cowdin R, Li X, Bernstein L, McTiernan A, Ballard-Barbash R, Gauderman WJ, Gilliland F. The ADRB3 Trp64Arg variant and obesity in African-American breast cancer cases. Int J Obes (Lond) 2007, 31:1110-1118. 17264845, 10.1038/sj.ijo.0803554.
8. Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers T. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res Treat 2007, 104:197-209. 17051426, 10.1007/s10549-006-9403-9.
9. Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A. Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis 2006, 27:1867-1875. 16606630, 10.1093/carcin/bgl036.
10. Wagner K, Hemminki K, Grzybowska E, Klaes R, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A. The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer. Carcinogenesis 2004, 25:2473-2478. 15308584, 10.1093/carcin/bgh263.
11. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004, 13:1206-1214.
12. Skibola DR, Smith MT, Bracci PM, Hubbard AE, Agana L, Chi S, Holly EA. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2005, 14:1251-1256. 15894681, 10.1158/1055-9965.EPI-04-0895.
13. Arcuri F, Sestini S, Ricci C, Runci Y, Carducci A, Paulesu L, Cintorino M. Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 2000, 72:239-247. 10822013, 10.1016/S0960-0760(00)00039-X.
14. Cesarone G, Edupuganti OP, Chen CP, Wickstrom E. Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem 2007, 18:1831-1840. 17922544, 10.1021/bc070135v.
15. Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, Shaw LM. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol 2006, 26:9338-9351. 17030605, 10.1128/MCB.01032-06, 1698550.
16. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002, 94:2490-2501. 12015775, 10.1002/cncr.101970.
17. International HapMap Project. , http://www.hapmap.org
18. dbSNP. , http://www.ncbi.nlm.nih.gov/SNP/
19. Barrett J, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 15297300, 10.1093/bioinformatics/bth457.
20. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223. 16244653, 10.1038/ng1669.
21. Autoprimer.com. , http://www.autoprimer.com
22. Stram D, Haiman C, Hirschhorn J, Altshuler D, Kolonel L, Henderson B, Pike M. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003, 55:27-36. 12890923, 10.1159/000071807.
23. Feigelson H, Jonas C, Teras L, Thun M, Calle E. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004, 13:220-224. 14973094, 10.1158/1055-9965.EPI-03-0301.
24. Huang Z, Hankinson S, Colditz G, Stampfer M, Hunter D, Manson J, Hennekens C, Rosner B, Speizer F, Willett W. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997, 278:1407-1411. 9355998, 10.1001/jama.278.17.1407.
25. Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91:2295-2302. 16551740, 10.1210/jc.2005-2222.
26. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF, Hoover RN, Thomas G, Chanock SJ. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39:870-874. 17529973, 10.1038/ng2075.
27. CGEMS: Cancer Genetic Markers of Susceptibility. , http://cgems.cancer.gov/data
28. Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D'Agostino RB, Atwood LD. Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab 2005, 90:3197-3201. 15769990, 10.1210/jc.2004-1752.
29. Smit P, Dekker MJ, de Jong FJ, Beld AW, Koper JW, Pols HA, Brinkmann AO, de Jong FH, Breteler MM, Lamberts SW. Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia. J Clin Endocrinol Metab 2007, 92:359-362. 17062770, 10.1210/jc.2006-1349.
30. Lautier C, ElMkadem S, Renard E, Brun J, Gris J, Bringer J, Grigorescu F. Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet 2003, 113:34-43.
31. Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Wolff R, Caan BJ, Slattery ML. Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2005, 14:1802-1809. 16030120, 10.1158/1055-9965.EPI-05-0149.
32. Saunders CL, Chiodini BD, Sham P, Lewis CM, Abkevich V, Adeyemo AA, de Andrade M, Arya R, Berenson GS, Blangero J, Boehnke M, Borecki IB, Chagnon YC, Chen W, Comuzzie AG, Deng HW, Duggirala R, Feitosa MF, Froguel P, Hanson RL, Hebebrand J, Huezo-Dias P, Kissebah AH, Li W, Luke A, Martin LJ, Nash M, Ohman M, Palmer LJ, Peltonen L, et al. Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity (Silver Spring) 2007, 15:2263-2275. 17890495, 10.1038/oby.2007.269.